Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 3 1Phase 1 1

Status

Withdrawn 1Unknown 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Gastrointestinal 2Thoracic 1Head & Neck 1Breast 1

Conditions

Breast Neoplasms 13110Neoplasms 10462Carcinoma, Non-Small-Cell Lung 6857Prostatic Neoplasms 6258Colorectal Neoplasms 5925Lung Neoplasms 5091Multiple Myeloma 3568Pancreatic Neoplasms 3552Leukemia, Myeloid, Acute 3503Neoplasm Metastasis 3499Carcinoma, Hepatocellular 3264Ovarian Neoplasms 3160Melanoma 3134Stomach Neoplasms 3051Lymphoma 2981Head and Neck Neoplasms 2595Recurrence 2548Precursor Cell Lymphoblastic Leukemia-Lymphoma 2496Leukemia 2360Colonic Neoplasms 2326Brain Neoplasms 2306Lymphoma, Non-Hodgkin 2265Rectal Neoplasms 2186Uterine Cervical Neoplasms 2182Glioblastoma 2010Leukemia, Lymphocytic, Chronic, B-Cell 1992Carcinoma, Renal Cell 1910Squamous Cell Carcinoma of Head and Neck 1875Lymphoma, Follicular 1847Esophageal Neoplasms 1797

Interventions

Surveys and Questionnaires 1Saline Solution 1Ringer's Lactate 1Remifentanil 1Oncolytic Virotherapy 1Ofloxacin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Ear Neoplasms × Clear all
NCT06803381 2025-02-06

SOMEST'ALIM2

Hospices Civils de Lyon

Not yet recruiting
96 enrolled
BreastGastrointestinalThoracic

Breast Neoplasms, Ear Neoplasms, Gastrointestinal Neoplasms, Lung Neoplasms, Neoplasms, Nose Neoplasms

NCT05830240 2023-04-26

A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Relapsed/Refractory Head and Neck Cancer

Shanghai Yunying Medical Technology

Phase EARLY_PHASE1 Unknown
9 enrolled
GastrointestinalHead & Neck

Ear Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Laryngeal Neoplasms, Nose Neoplasms, Otorhinolaryngologic Neoplasms, Pharyngeal Neoplasms

NCT00584155 2015-05-27

Protection From Cisplatin Ototoxicity by Lactated Ringers

University of Oklahoma

Phase 1 Withdrawn

Ear Neoplasms, Hearing Loss

NCT02093143 2014-03-20

ENDOTANIL

Centre Hospitalier Universitaire de Besancon

Phase 3 Completed
256 enrolled

Ear Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡